
浏览全部资源
扫码关注微信
400010 重庆,重庆医科大学附属第二医院乳腺甲状腺外科
[明佳,E-mail: mingjia@cqmu.edu.cnMING Jia, E-mail: mingjia@cqmu.edu.cn
收稿:2023-03-15,
修回:2023-05-24,
纸质出版:2023-09-30
移动端阅览
杨婷, 王廷睿, 韩珊珊, 等. LINC00294通过AKT/mTOR/HIF-1a通路促进乳腺癌细胞的增殖、侵袭与迁移[J]. 陆军军医大学学报, 2023,45(18):1927-1936.
Ting YANG, Tingrui WANG, Shanshan HAN, et al. LINC00294 promotes proliferation, invasion, and migration of breast cancer cells
杨婷, 王廷睿, 韩珊珊, 等. LINC00294通过AKT/mTOR/HIF-1a通路促进乳腺癌细胞的增殖、侵袭与迁移[J]. 陆军军医大学学报, 2023,45(18):1927-1936. DOI: 10.16016/j.2097-0927.202303100.
Ting YANG, Tingrui WANG, Shanshan HAN, et al. LINC00294 promotes proliferation, invasion, and migration of breast cancer cells
目的
2
探讨长链非编码RNA(long non-coding RNA
LncRNA)LINC00294在乳腺癌组织和细胞中的表达变化,及其对乳腺癌细胞生物学特性的影响和可能的机制。
方法
2
利用GEO数据库资源(GSE45827)中的41例乳腺癌组织和11例癌旁组织转录组测序数据分析差异基因,采用qRT-PCR实验检测20对来自本院2021-2022年确诊的乳腺癌患者的癌组织和癌旁组织,以及正常人乳腺上皮细胞MCF-10A和人乳腺癌细胞MCF-7、SK-BR-3和MDA-MB-231中LINC00294的表达;干扰LINC00294后采用CCK-8检测细胞增殖变化;采用流式细胞术、Western blot检测细胞凋亡和相关蛋白表达变化;采用划痕实验和Transwell检测细胞迁移和侵袭;裸鼠原位成瘤实验检测干扰LINC00294对体内肿瘤生长的影响;采用Western blot检测干扰LINC00294后AKT/mTOR通路相关蛋白p-mTOR、mTOR、p-AKT、AKT及其下游靶分子缺氧诱导因子-1(hypoxia inducible factor-1
α
,HIF-1
α
)的表达情况。
结果
2
通过GEO数据库筛选出差异表达的基因LINC00294;LINC00294在乳腺癌组织和乳腺癌细胞MCF-7、SK-BR-3和MDA-MB-231中表达显著增高(
P
<
0.05);干扰LINC00294后MCF-7细胞增殖能力下降、凋亡相关蛋白表达增加、侵袭和迁移能力下降(
P
<
0.05)。干扰HIF-1
α
可以抑制LINC00294的表达(
P
<
0.05);干扰LINC00294后AKT/mTOR信号通路中p-AKT和p-mTOR蛋白及其下游靶分子HIF-1
α
的表达减少(
P
<
0.05)。
结论
2
乳腺癌中高表达的LINC00294可能通过AKT/mTOR/HIF-1
α
信号通路影响乳腺癌的增殖、侵袭和迁移等,LINC00294可能与乳腺癌的发展密切相关。
Objective
2
To explore the changes in the expression of long non-coding RNA (LncRNA) LINC00294 in breast cancer tissues and cells
and investigate its effects and the possible mechanisms on the biological properties of breast cancer cells.
Methods
2
The differentially expressed genes (DEGs) were analyzed using transcriptome sequencing data from 41 breast cancer tissues and 11 para-cancerous tissues from the Gene Expression Omnibus (GEO) database (GSE45827). Then qRT-PCR assay was used to measure the expression of LINC00294 in 20 pairs of breast cancer and para-cancerous tissues from the breast cancer patients diagnosed in our department
as well as in the normal human breast epithelial MCF-10A cells and the human breast cancer cell lines MCF-7
K-BR-3 and MDA-MB-231. After MCF-7 cells were transfected with lentiviral vector of si-LINC to interfere LINC00294 expression
CCK-8 assay was used to detect cell proliferation
flow cytometry and Western blotting were employed to measure cell apoptosis and expression of related proteins
cell scratch assay and Transwell assay were applied to observe cell migration and invasion. Then
the effect of interference with LINC00294 on tumor growth in nude mice model of
in situ
subcutaneous tumorigenesis was observed. The expression of AKT/mTOR pathway-related proteins p-mTOR
mTOR
p-AKT
AKT
and its downstream target molecule HIF-1
α
was detected by Western blotting.
Results
2
LncRNA LINC00294 was screened out as a DEG in breast cancer tissues from the GEO database. It was also highly expressed in breast cancer tissues and MCF-7
SK-BR-3 and MDA-MB-231 cells (
P
<
0.05). Interference of LINC00294 resulted in reduced proliferation
enhanced expression of apoptosis-related proteins
and decreased invasion and migration abilities in MCF-7 cells (
P
<
0.05). The expression of LINC00294 was inhibited by HIF-1
α
interference (
P
<
0.05)
and LINC00294 interference decreased the expression of p-AKT
p-mTOR
mTOR and its downstream target molecule HIF-1
α
in the AKT/mTOR signaling pathway (
P
<
0.05).
Conclusion
2
High expression of LINC00294 in breast cancer may affect the proliferation
invasion
and migration of breast cancer through the AKT/mTOR/HIF-1
α
signaling pathway
and LINC00294 may be closely associated with the pathogenesis of breast cancer.
SUNG H, FERLAY J, SIEGEL R L, et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
WANG J, TAN L R, YU X T, et al . LncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m 6 A reader YTHDC2[J ] . Mol Cancer, 2022, 21(1): 229. DOI: 10.1186/s12943-022-01705-7..
罗毅, 房晓瑜, 谢薇佳, 等. 长链非编码RNA LINC02163在肝细胞肝癌中表达上调并促进肝癌细胞迁移和侵袭[J]. 第三军医大学学报, 2020, 42(1): 81-87. DOI: 10.16016/j.1000-5404.201907251.
LUO Y, FANG X Y, XIE W J, et al . Long non-coding RNA LINC02163 is up-regulated and promotes cell migration and invasion in hepatocellular carcinoma[J ] . J Third Mil Med Univ, 2020, 42(1): 81-87. DOI: 10.16016/j.1000-5404.201907251.
CAI H Z, XU H F, LU H C, et al . LncRNA SNHG1 facilitates tumor proliferation and represses apoptosis by regulating PPARγ ubiquitination in bladder cancer[J ] . Cancers, 2022, 14(19): 4740. DOI: 10.3390/cancers14194740.
FAN C N, WANG Q, KUIPERS T B, et al . LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradation[J ] . EMBO J, 2023, 42(10): e112806. DOI: 10.15252/embj.2022112806.
PAN Y H, LU X X, SHU G N, et al . Extracellular vesicle-mediated transfer of LncRNA IGFL2-AS1 confers sunitinib resistance in renal cell carcinoma[J ] .Cancer Res, 2023, 83(1): 103-116. DOI: 10.1158/0008-5472.CAN-21-3432.
ZHANG C X, JIFU E, YU E D. LncRNA CASC21 induces HGH1 to mediate colorectal cancer cell proliferation, migration, EMT and stemness[J]. RNA Biol, 2021, 18(sup1): 369-381. DOI: 10.1080/15476286.2021.1950464.
ZHANG M, WANG N, SONG P, et al . LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1[J ] . Cell Prolif, 2020, 53(9): e12855. DOI: 10.1111/cpr.12855.
FENG C J, ZH AO Y, LI Y J, et al . LncRNA MALAT1 promotes lung cancer proliferation and gefitinib resistance by acting as a miR-200a sponge[J ] . Arch De Bronconeumología, 2019, 55(12): 627-633. DOI: 10.1016/j.arbres.2019.03.026.
YU Y, LV F, LIANG D, et al . HOTAIR may regulate proliferation, apoptosis, migration and invasion of MCF-7 cells through regulating the P53/Akt/JNK signaling pathway[J ] . Biomed Pharmacother, 2017, 90: 555-561. DOI: 10.1016/j.biopha.2017.03.054.
杨鑫, 陈力. 敲低长链非编码RNA GK-IT1抑制食管鳞状癌细胞增殖和促进凋亡[J]. 第三军医大学学报, 2021, 43(2): 146-155. DOI: 10.16016/j.1000-5404.202008083.
YANG X, CHEN L. Knock-down of long non-codingRNA GK-IT1 inhibits proliferation and promotes apoptosis in esophageal carcinoma cells[J]. J Third Mil Med Univ, 2021, 43(2): 146-155. DOI: 10.16016/j.1000-5404.202008083.
SLACK F J, CHINNAIYAN A M. The role of non-coding RNAs in oncology[J]. Cell, 2019, 179(5): 1033-1055. DOI: 10.1016/j.cell.2019.10.017.
LIU S Q, SUN Y, HOU Y X, et al . A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties[J ] . J Hematol Oncol, 2021, 14(1): 178. DOI: 10.1186/s13045-021-01194-z.
HU H T, ZHANG H Q, XING Y, et al . The lncRNA THOR interacts with and stabilizes hnRNPD to promote cell proliferation and metastasis in breast cancer[J ] . Oncogene, 2022, 41(49): 5298-5314. DOI: 10.1038/s41388-022-02495-4..
LUO A R, LAN X X, QIU Q Z, et al . LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation[J ] . Cell Death Dis, 2022, 13(11): 936. DOI: 10.1038/s41419-022-05359-7.
DONG X G, PI Q, YUEMAIERABOLA A, et al . Silencing LINC00294 restores mitochondrial function and inhibits apoptosis of glioma cells under hypoxia via the miR-21-5p/CASKIN1/cAMP axis[J ] . Oxidative Med Cell Longev, 2021, 2021: 1-21. DOI: 10.1155/2021/8240015..
ZHOU X K, LV L, ZHANG Z Y, et al . LINC00294 negatively modulates cell proliferation in glioma through a neurofilament medium-mediated pathway via interacting with miR-1278[J ] . J Gene Med, 2020, 22(10): e3235. DOI: 10.1002/jgm.3235..
QIU J N, ZHOU S L, CHENG W J, et al . LINC00294 induced by GRP78 promotes cervical cancer development by promoting cell cycle transition[J ] . Oncol Lett, 2020, 20(5): 1. DOI: 10.3892/ol.2020.12125.
XU J C, FENG H, MA L, et al . Bak kenolide-Ⅲa ameliorates lipopolysaccharide-induced inflammatory injury in human umbilical vein endothelial cells by upregulating LINC00294[J ] . Mol Med Rep, 2021, 23(5): 377. DOI: 10.3892/mmr.2021.12016.
UCARYILMAZ METIN C, OZCAN G. The HIF-1 α as a potent inducer of the hallmarks in gastric cancer[J ] . Cancers, 2022, 14(11): 2711. DOI: 10.3390/cancers14112711.
MULTHOFF G, VAUPEL P. Hypoxia compromises anti-cancer immune responses[M]// Oxygen Transport to Tissue XLI. Cham: Springer, 2020: 131-143.10.1007/978-3-030-34461-0_18.
LIU Q, GUAN C C, LIU C, et al . Targeting hypoxia-inducible factor-1alpha: a new strategy for triple-negative breast cancer therapy[J ] . Biomed Pharmacother, 2022, 156: 113861. DOI: 10.1016/j.biopha.2022.113861.
YU L, WEI J, LIU P D. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J]. Semin Cancer Biol, 2022, 85: 69-94. DOI: 10.1016/j.semcancer.2021.06.019.
WANG X H, XU Y Z, WANG X J, et al . LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2[J ] . Cell Prolif, 2017, 50(6): e12395. DOI: 10.1111/cpr.12395.
LI Y, TSANG C K, WANG S H, et al . MAF 1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription[J ] . Hepatology, 2016, 63(6): 1928-1942. DOI: 10.1002/hep.28507..
TU Z B, HU Y, RAIZADA D, et al . Long noncoding RNA-mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K intriple-negative breast cancer[J ] . Proc Natl Acad Sci USA, 2022, 119(43): e2203180119. DOI: 10.1073/pnas.2203180119.
WU X S, WANG F, LI H F, et al . LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis[J ] . EMBO Rep, 2017, 18(10): 1837-1853. DOI: 10.15252/embr.201744147.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621